Bruce W Penman

Title: Bruce W. Penman: Innovator in Mutagenesis Assays

Introduction

Bruce W. Penman is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of genetics, particularly in the area of mutagenesis. His work has implications for understanding genetic damage and its effects on human health.

Latest Patents

Penman holds a patent for an "Assay for mutagenesis in heterozygous diploid human lymphoblasts." This assay is designed to determine mutagenic damage caused by the administration of known or suspected mutagens to diploid human lymphoblastoid cell lines. The assay utilizes gene loci for thymidine kinase, uridine kinase, or cytidine deaminase. By employing heterozygotes of human lymphoblastoid cells, this innovative approach allows for a more accurate assessment of mutagenic effects.

Career Highlights

Bruce W. Penman is affiliated with the Massachusetts Institute of Technology, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding of mutagenesis and its implications for human health.

Collaborations

Throughout his career, Penman has collaborated with esteemed colleagues, including Thomas R. Skopek and Howard L. Liber. These collaborations have further enriched his research and contributed to the scientific community's understanding of genetic mutations.

Conclusion

In summary, Bruce W. Penman is a distinguished inventor whose work in mutagenesis assays has made a significant impact in the field of genetics. His innovative approaches continue to influence research and understanding in this critical area of study.